Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods
US8852163B2 · kind B2 · utility
70Cited by
381References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2013 |
| Grant date | Oct 7, 2014 |
| Priority date | — |
| Expiry date | Jun 28, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2007/003
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.